Correlation Between Molecular Partners and Adicet Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Adicet Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Adicet Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Adicet Bio, you can compare the effects of market volatilities on Molecular Partners and Adicet Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Adicet Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Adicet Bio.

Diversification Opportunities for Molecular Partners and Adicet Bio

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Molecular and Adicet is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Adicet Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adicet Bio and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Adicet Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adicet Bio has no effect on the direction of Molecular Partners i.e., Molecular Partners and Adicet Bio go up and down completely randomly.

Pair Corralation between Molecular Partners and Adicet Bio

Given the investment horizon of 90 days Molecular Partners AG is expected to generate 0.92 times more return on investment than Adicet Bio. However, Molecular Partners AG is 1.08 times less risky than Adicet Bio. It trades about 0.02 of its potential returns per unit of risk. Adicet Bio is currently generating about -0.03 per unit of risk. If you would invest  693.00  in Molecular Partners AG on August 31, 2024 and sell it today you would lose (111.00) from holding Molecular Partners AG or give up 16.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Molecular Partners AG  vs.  Adicet Bio

 Performance 
       Timeline  
Molecular Partners 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Molecular Partners AG are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Molecular Partners displayed solid returns over the last few months and may actually be approaching a breakup point.
Adicet Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adicet Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Molecular Partners and Adicet Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Molecular Partners and Adicet Bio

The main advantage of trading using opposite Molecular Partners and Adicet Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Adicet Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adicet Bio will offset losses from the drop in Adicet Bio's long position.
The idea behind Molecular Partners AG and Adicet Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites